Optimizing Care Across the Continuum: Updates in the Detection and Treatment of Prostate Cancer : Episode 3
Data from the DEAR Real-World Study and Strategies for Optimizing Outcomes
Drs. Dorff and McKay discuss real-world data from DEAR trial comparing darolutamide, enzalutamide and apalutamide, providing clinical pearls on their experiences to optimize outcomes.
EP: 1.Evolving Paradigms in the Detection and Treatment of Prostate Cancer
EP: 2.Evolving Insights into Castration Resistance: Novel Biomarkers Predicting Disease Progression
Now Viewing
EP: 3.Data from the DEAR Real-World Study and Strategies for Optimizing Outcomes
EP: 4.Revolutionizing Prostate Cancer Care: 2023’s Transformative Breakthroughs
Related Videos
Related Content
